|
|
|
|
|
|
|
|
open access :
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer : British Journal of Cancer
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.